ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2021

Budget Impact Analysis of the Introduction of Rituximab and Trastuzumab Intravenous Biosimilars to EU-5 Markets.

Minyoung Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.